CD147 is reported to affect angiogenesis mainly via three mechanisms: a) Inducing proteinases which cleave VEGF from the ECM; b) Stimulating the production of tumor-derived VEGF; and c) Increasing VEGFR2 expression on the endothelial cells [59]. This evidence concerns the gene KDR and neoplasm.